HomeInsightsEPS

Kabra Drugs Ltd EPS

Kabra Drugs Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 30, 2024)

stocks purchased

0.9 K

Stocks Traded

(Dec 30, 2024)

Last Updated on: Jan 06, 2025

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

EPS

₹ -1.41

Last updated on: Dec 30, 2025

Key Highlights

  • The Earning per Share of Kabra Drugs Ltd is ₹ -1.41 as of 30 Dec 24 .
  • The earning per share of Kabra Drugs Ltd changed from ₹ -0.28 to ₹ -0.39 over 6 quarters. This represents a CAGR of 24.72% .

Historical Earning per Share of Kabra Drugs Ltd

No data available

* All values are in

Company Fundamentals for Kabra Drugs Ltd

Market Cap

10 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

3.1

Day’s High *

10.06

Day’s Low

10.06

DTE *

0.2

ROE *

-43.3

52 Week High

10.06

52 Week Low

5.93

ROCE *

-36.3

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 Dec 202410.06
23 Dec 202410.06
16 Dec 202410.06
09 Dec 20249.59
02 Dec 20249.59
25 Nov 20249.59
18 Nov 20249.59
11 Nov 20249.59
04 Nov 20249.14
28 Oct 20249.14

BlinkX Score for Kabra Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

10

Asset Value

5

1.2 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Kabra Drugs Ltd010
Sun Pharmaceuticals Industries Ltd464,43,661
Divis Laboratories Ltd691,60,496
Cipla Ltd571,21,970
Mankind Pharma Ltd511,21,222
Torrent Pharmaceuticals Ltd511,15,066

Historical Market Cap of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Kabra Drugs Ltd News Hub

News

Kabra Drugs to conduct EGM

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be ...

Read more

05 Dec 2024 17:27

News

Kabra Drugs schedules board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 December 202...

Read more

26 Nov 2024 09:56

News

Kabra Drugs to convene board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 November 20...

Read more

08 Nov 2024 12:27

News

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 202...

Read more

22 Oct 2024 11:01

News

Kabra Drugs to hold AGM

Kabra Drugs announced that the 35th Annual General Meeting (AGM) of the company will be he...

Read more

16 Sep 2024 09:56

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 20...

Read more

28 Aug 2024 14:54

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Kabra Drugs Ltd

What is the EPS of Kabra Drugs Ltd stock?

The Earnings Per Share (EPS) of Kabra Drugs Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Kabra Drugs Ltd EPS calculated?

The EPS of Kabra Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Kabra Drugs Ltd report its EPS?

Kabra Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Kabra Drugs Ltd EPS?

Factors that influence the EPS of Kabra Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Kabra Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Kabra Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions